Citation Tools
Speaker abstracts 2001
Rheumatoid Arthritis – Treatment
FRI0059 The efficacy and safety of pegylated recombinant methionyl human soluble tumour necrosis factor receptor type i (peg stnf-ri; p55) in a randomised, placebo-controlled, clinical study of patients with rheumatoid arthritis (ra)
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- FRI0059 The efficacy and safety of pegylated recombinant methionyl human soluble tumour necrosis factor receptor type i (peg stnf-ri; p55) in a randomised, placebo-controlled, clinical study of patients with rheumatoid arthritis (ra)